Porous polysaccharide scaffold comprising nano-hydroxyapatite and use for bone formation

US10143774B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10143774-B2
Application numberUS-201715657868-A
CountryUS
Kind codeB2
Filing dateJul 24, 2017
Priority dateAug 31, 2010
Publication dateDec 4, 2018
Grant dateDec 4, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relate to three dimensional porous polysaccharide matrices able to induce mineralization of a tissue in osseous site, as well as in non-osseous site, in the absence of stem cells or growth factors.

First claim

Opening claim text (preview).

The invention claimed is: 1. A porous polysaccharide scaffold obtained by: i) preparing an alkaline aqueous solution comprising at least one polysaccharide, a cross-linking agent and a porogen agent, ii) transforming the solution into a hydrogel by placing said solution at a temperature from 4° C. to 80° C. for a sufficient time to allow cross-linking of said at least one polysaccharide, iii) submerging said hydrogel into a solvent, and iv) washing the porous polysaccharide scaffold obtained at step iii), wherein the alkaline aqueous solution of step i) further comprises hydroxyapatite and wherein the porous polysaccharide scaffold lacks exogenously added cells and growth factors. 2. The porous polysaccharide scaffold according to claim 1 , wherein the porogen agent is selected from the group consisting of sodium chloride, calcium chloride, ammonium carbonate, ammonium bicarbonate, calcium carbonate, sodium carbonate, sodium bicarbonate and mixtures thereof. 3. The porous polysaccharide scaffold according to claim 1 , wherein a weight ratio of the at least one polysaccharide to the porogen agent is in a range from 1:50 to 50:1. 4. The porous polysaccharide scaffold according to claim 1 , wherein said at least one polysaccharide is selected from the group consisting of dextran, pullulan, agar, alginic acid, starch, hyaluronic acid, inulin, heparin, fucoidan, chitosan and mixtures thereof. 5. The porous polysaccharide scaffold according to claim 1 , wherein said at least one polysaccharide is a mixture of pullulan/dextran in a ratio in a range from 95:5 to 5:95. 6. The porous polysaccharide scaffold according to claim 1 , wherein said at least one polysaccharide is a mixture of pullulan/dextran/fucoidan in a ratio in a range from 70:20:10 to 50:20:30. 7. The porous polysaccharide scaffold according to claim 1 , wherein said cross-linking agent is selected from the group consisting of trisodium trimetaphosphate (STMP), phosphorus oxychloride (POCl 3 ), epichlorohydrin, formaldehydes, carbodiimides, glutaraldehydes, and mixtures thereof. 8. The porous polysaccharide scaffold according to claim 1 , wherein said hydroxyapatite is nano-hydroxyapatite. 9. The porous polysaccharide scaffold according to claim 8 wherein said nano-hydroxyapatite is obtained from a solution of phosphoric acid at a concentration between 0.3 to 1M, with a solution of calcium hydroxide at a concentration between 0.5 to 1.5M, through chemical precipitation at room temperature. 10. The porous polysaccharide scaffold according to claim 9 , wherein said phosphoric acid concentration is 0.6M and said calcium hydroxide concentration is 1M. 11. The porous polysaccharide scaffold of claim 10 , wherein said nano-hydroxide concentration is between 0.1 and 0.5% (w/v) or between 0.1 and 0.3% (w/v). 12. The porous polysaccharide scaffold according to claim 8 wherein a concentration of nano-hydroxyapatite in the alkaline aqueous solution is between 0.01 and 10% (w/v). 13. The porous polysaccharide scaffold according to claim 1 , wherein said porous polysaccharide scaffold contains pores from 1 μm to 500 μm in size and the porosity is from 4% to 75%. 14. The porous polysaccharide scaffold of claim 13 , wherein the pores are from 10 to 200 μm in size and the porosity is from 4% to 50%. 15. The porous polysaccharide scaffold according to claim 1 wherein said solvent is an aqueous solution. 16. The porous polysaccharide scaffold according to claim 1 , wherein a weight ratio of the at least one polysaccharide to said porogen agent is in a range from 1:30 to 30:1 (w/w). 17. The porous polysaccharide scaffold according to claim 16 , wherein said weight ratio is 75:25 (w/w). 18. The porous polysaccharide scaffold according to claim 16 , wherein said ratio is selected from the group consisting of 70:20:10 (w/w), 50:30:20 (w/w), and 73:22:5 (w/w).

Assignees

Inventors

Classifications

  • Methods for forming porous structures using a negative form which is filled and then removed by pyrolysis or dissolution · CPC title

  • Salts · CPC title

  • A61L27/20Primary

    Polysaccharides · CPC title

  • with phosphorus-containing inorganic fillers · CPC title

  • by elimination of a solid phase from a macromolecular composition or article, e.g. leaching out · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10143774B2 cover?
The present invention relate to three dimensional porous polysaccharide matrices able to induce mineralization of a tissue in osseous site, as well as in non-osseous site, in the absence of stem cells or growth factors.
Who is the assignee on this patent?
Amedee Joelle, Letourneur Didier, Le Visage Catherine, and 6 more
What technology area does this patent fall under?
Primary CPC classification A61L27/20. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).